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CHAPTER 1. GENERAL INTRODUCTION 
 
Dissertation Organization 
This dissertation begins with a general introduction. The following chapters are presented as 
two complete scientific manuscripts, each followed by cited literature, tables and figures. 
General conclusions summarize the work and provide some perspective for future research. 
General Introduction 
Ever since the first optical detection of small single molecules in the late 1980s1,2, the study 
of the single molecule has bloomed over a decade, enriching the world with new information 
from the nanoscopic world. Early studies extensively explored individual molecule’s 
physical properties such as diffusion3,4, interactions of individual molecules5-10, surface 
adsorption and interaction11, conformational dynamics12-19 and single molecule scale 
reaction20-23. The information from individual molecules, not scrambled by ensemble average, 
provided a whole new scope in science. 
Soon after the single molecule detection technique emerged, it was also applied to biological 
and clinical fields. Research in areas such as high throughput DNA screening and single-
molecule immunoassay24, sizing and sorting  of DNA25-29, and single molecule imaging in 
living cells30,31 were carried out. Some have elucidated single molecule-level mechanisms in 
bulk analytical separation procedures, such as gel electrophoresis32,33, liquid chromatography 
and capillary electrophoresis34-36.   Now the technique’s contribution in genetic and 
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medicinal studies is bigger than ever, providing ultimate sensitivity and selectivity to trace 
and identify low copy number target bio-molecules. In the new millennium, more strategies 
to identify and quantify single molecule nucleic acid and proteins were continuously 
developed. New devices were elaborated37-41 to facilitate individual molecule’s detection and 
counting. Novel fluorescence labeling agents other than organic dyes were also successfully 
utilized in single biomolecule imaging.42,43 The single molecule detection technique was also 
applied in common tasks in genetics such as single nucleotide polymorphism (SNP) 
detection44-49, mRNA quantification and gene expression study50,51,  sequencing52-55 and 
DNA mapping56,57, suggesting its huge potential as a standard detection method. Physical 
properties of single biomolecules also continued to be investigated intensely58-62.  
Since the ultimate detection limit for any analytical assay will be counting targets one by 
one63, the importance of single molecule detection was appreciated in many fields where an 
ultrasensitive detection technique is crucial, such as clinical screening.  Sensitive detection 
methods mean less pathogen or abnormal targets are required to be detected, and lead to the 
possibility of earlier diagnosis. When they are discovered at an early stage, diseases can be 
treated faster, and the chance to achieve a complete cure is higher.  
With its sensitivity usually higher than conventional bulk detection methods by at least 10-
100 times, single molecule detection is a good candidate for a next-generation disease 
screening method.  Many attempts have been made to detect specific sequence DNA and 
proteins of clinical interest at the single molecule level64. They successfully demonstrated 
detection limits lower than conventional bulk analyses, without amplification.   
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In practical clinical screening, however, the low copy number target molecules are mixed 
with an overwhelming excess of similar non-targets. Cancer cells with inherited mutation, for 
example, contain one or two copies of mutation in a cell, and the chance to find the DNA 
fragment that carries the mutated site in the entire genome mixture is nearly one out of a 
million. The ambiguity caused by non-targets is one of the biggest obstacles in biological and 
clinical analysis. Thorough identification, not just detection, is required. With single 
molecule detection, the information can be achieved from individual target molecules, apart 
from its background-generating large amount of non-targets, once proper labeling strategy is 
incorporated. 
As much as sensitivity and selectivity, accuracy is another important aspect that a good 
clinical screening method should possess. One should detect or quantify the target with the 
least error. In many assays employed in clinical screening, the target molecule or the signal is 
often amplified to help detection at lower target concentration. In polymerase chain reaction 
(PCR), for example, a designated sequence of DNA is selectively amplified in repeated 
temperature cycles. It certainly helps in detecting low copy number pathogen or abnormal 
DNA with high selectivity and sensitivity, but its problems are also well known. Since 
amplification is very effective, a small contamination can be amplified as well and lead to an 
error. Amplification is exponential rather than linear, which makes quantification of the 
sample complicated. The efficiency of the reaction itself depends on many factors such as 
enzyme activity, temperature and metal ion concentration that should be controlled 
accurately altogether. In the mean time, however, single molecule detection can skip these 
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steps, avoiding problems caused in the course of the amplification procedure and hence 
provides less error-prone detection.  
Bio-polymers such as DNA and proteins are large in size and can have multiple fluorophores 
in one molecule, which facilitates single molecule fluorescence imaging. With imaging, a 
large number of molecules can be analyzed at the same time in a frame of a movie. This 
makes the screening even faster with higher throughput. However, faster and more sensitive 
detection can further suggest something beyond just lower detection limit or higher 
throughput; sample preparation steps can be minimized as well. It takes less than a second to 
image and identify molecules in one movie frame, and the detection procedure can be 
completed before the sample-destroying reaction may proceed too far, eliminating the 
necessity of a clean up procedure. The ability to image molecules clearly with a high signal-
to-noise ratio means the presence of impurities can be tolerated to some extent. Eliminating 
one preparation procedure can be important in situations where many samples have to be 
analyzed, or short sample handling time is crucial.  
Here, we present the potential of single molecule imaging as a clinical screening method. 
DNA targets were detected and identified with electrophoretic mobility and a combination of 
probe colors. Along with the purified target-only sample, real pathogen DNA of human 
papillomavirus (HPV) type-16 in human genomic DNA was detected and quantified. 
Strategies to make the target appear more distinctively and selectively were exploited using 
fluorescence resonance energy transfer (FRET) with multiple color dyes, surface 
hybridization with washing steps to eliminate excessive non-target molecules, and a 
combination of two different phase probes (one tethered on the surface, the other in free 
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solution). They were tested with cell cultures and actual clinical samples and proved to be 
accurate, meaning our single molecule detection can indeed be a good clinical analysis 
method. 
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CHAPTER 2.  MOLECULAR IDENTIFICATION OF NUCLEIC ACID WITH 
CAPILLARY ELECTROPHORESIS AND SINGLE MOLECULE SPECTROSCOPY∗
 
Introduction 
Single molecule detection has been successfully applied to various genetic studies: small 
abnormality detection in bio-molecules1-4, quantification of gene expression5,6, DNA and 
protein binding mechanisms and enzyme kinetics studies7,8. Mutation or single nucleotide 
polymorphism (SNP) detection was one of the most actively studied areas using single 
molecules, suggesting its further application as a clinical screening method.  
In genetic and clinical studies dealing with nucleic acids, using sequence specificity is the 
most common way of differentiation. Restriction enzymes that recognize and cleave certain 
sequences of nucleic acid are often used to detect sequence difference or mutation (restriction 
fragment length polymorphism, RFLP9). A single nucleotide difference can eliminate or 
create a cutting site of a restriction enzyme and result in different size fragments from wild 
type digestion. When the mutation site does not have an enzyme cutting site, PCR 
amplification was used to add the site near mutation and amplify10. Once a different size 
fragment is generated, gel electrophoresis is typically used for separation and identification. 
However, conventional slab-gel electrophoresis is slow and insensitive. A single molecule 
scale substitute will provide a good answer to solve these problems. Several attempts have 
                                                 
∗ Reprinted in part from Journal of Chromatography A, 1053 (2004), Ji-young Lee; Hung-Wing Li; 
Edward S. Yeung, Single-molecule spectroscopy for molecular identification in capillary electrophoresis, 
173–179, Copyright(2004), with permission from Elsevier 
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been made to scale down restriction fingerprinting and gel electrophoresis11-13, but often the 
preparation and detection were still complicated, and the number of molecules analyzed at 
one time was low. 
Hybridization of labeled probe molecules to target is another strategy in genetics. Nucleic 
acid’s ability to hybridize only with a complementary sequence makes a selective assay. This 
strategy was widely adopted in single molecule detection as well, where no bulk amount is 
needed to collect enough signals from targets. Probes labeled with a single fluorophore or 
more efficient quantum dot are hybridized to targets and create a unique signal, distinctive 
from unbound probes or non-targets. The FRET system was popularly employed to make the 
target hybrid look different as a well as a coincidence of two spectra.  
In this study, a new method of measuring the electophoretic mobility of individual molecules 
was tried. The single-molecule imaging procedure can measure the electrophoretic mobilities 
of many distinct molecules in a fraction of a second. The molecules are not separated as in 
conventional electrophoresis, but are simply identified and counted with close to 100% 
efficiency while they pass through the detection area (Figure 1). Virtually all electrophoresis-
based analysis protocols from slab gels to capillary electrophoresis should be adaptable to 
single-molecule detection.  
We have also developed a high-speed high-throughput single-molecule imaging technique 
for identifying molecules that are labeled with different dyes in free solution based on 
differences in their fluorescence emission spectra14. Recording the emission spectra of 
individual molecules is considered challenging, since only a limited number of photons can 
be collected from a molecule before photobleaching sets in14. Further, instrumental setup that 
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are employed in most single molecule spectroscopy investigations are complicated, involving 
filters, dichroic mirrors, and multiple detectors. However, in our system, simple insertion of a 
transmission grating in the fluorescence pathway allowed recording of the entire spectrum, 
rather than selected wavelengths through optical filters, without additional optics or detectors. 
The complete emission spectra of many individual molecules are imaged in the millisecond 
time scale and recorded simultaneously while they are freely moving in the observation 
region. This technique can be used for screening single molecules for disease markers and for 
monitoring individual molecular interactions at a rate of thousands of molecules per second.  
We combine the best features of electrophoretic and spectroscopic discrimination among 
single molecules. In addition to size-based identification, the spectral information from 
individual molecules was collected while it moved along the flow in a capillary under 
electrophoresis. At high signal-to-noise (S/N) conditions, electrophoresis provides confident 
identification of the molecules. At low S/N, the spectroscopic information allows 
identification even when the electrophoretic mobilities are similar. 
Beta-actin mRNA of ~600 nt in length was detected with single molecule detection in 
capillaries as well. The mRNA was probed by hybridization to fluorescently labeled cDNA, 
taking advantage of FRET. It was stained with Alexa Fluor 488 dye and hybridized to a 
synthetic cDNA probe which was over-labeled with Alexa Fluor 532 to be invisible.  After 
hybridization, energy transfer made the hybrid bright, with only Alexa Fluor 532 dye 
emission. Taking advantage of the sensitive and fast detection of single molecule 
spectroscopy, the target mRNA-cDNA hybrid was further imaged in the presence of bio-
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matrices such as blood, plasma and saliva. Its sensitivity allowed up to 50% of bio-matrix in 
the sample, suggesting less purification steps in sample preparation.  
 
I. Single-molecule spectroscopy for molecular identification 
in capillary electrophoresis 
 
Experimental Section 
Buffer solutions.   Polyoxyethylene-6-cetylether (C16E6) is a monomeric non-ionic 
surfactant used as the sieving matrix for the separation of DNA fragments in capillary 
electrophoresis15. 0.25% (w/w) C16E6 (Sigma, St. Louis, MO, USA) prepared in 10 mM 
Gly-Gly buffer (Sigma) was used in all experiments. Gly-Gly was dissolved in ultrapure 
water and adjusted to pH 8.2 by dropwise addition of 2 M of NaOH. The buffer solution was 
filtered with a 0.2 µm filter. C16E6 was dissolved in Gly-Gly buffer at 90 °C and cooled to 
room temperature with constant stirring at medium speed. The C16E6 solution was also 
filtered with a 0.2 µm filter before use.  
DNA samples.   For electrophoresis and spectroscopic experiments, M13mp18 (7249 bp) 
and M13KE (7222 bp) DNA were purchased from New England Biolabs. Both DNA were 
cut with Acc65I and BsmI restriction enzymes to generate 4497 and 2752 bp DNA fragments 
for M13mp18 and 7088 bp and 135 bp for M13KE. The resulting fragments were also 
labeled fluorescently; M13mp18 fragments were labeled with YOYO-I and M13KE 
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fragments with POPO-III. Both YOYO-I and POPO-III dyes were used at a ratio of one dye 
molecule per five base pairs according to the manufacturer’s instructions. All samples were 
allowed to incubate for 5 min before they were further diluted. Lambda DNA was prepared at 
a concentration of 200 pM and diluted to 0.2 pM. M13mp18 and M13KE DNA samples were 
prepared at 1.4 nM and diluted to 2.8 pM in 0.25% (w/w) C16E6 solution prior to the 
experiments. 
Instrument setup.   A 27 cm long square capillary (75 µm i.d. × 365 µm o.d.; Polymicro 
Technologies, Phoenix, AZ, USA) was used for all electrophoresis experiments. The 
capillary was mounted on a Bakalite holder, which was placed on a Zeiss Axioskop upright 
microscope. The light source and detection system were very similar to those used in 
previous studies done in our group16,17. A Uniphase (San Jose, CA, USA) argon ion laser 
operating at 488 nm with 12.2 mW output power was used as the excitation source. The laser 
beam was focused by a 2.5 cm focal length cylindrical lens (Edmund Industrial Optics, 
Barrington, NJ, USA) so that the focal point was at the center of the capillary. Fluorescence 
from single DNA molecules was collected with a Zeiss 20× Fluar (0.75 NA) microscope 
objective at right angle to the incident laser beam. Two 488 nm holographic notch filters 
(Keiser Optical, Ann Arbor, MI, USA; HNFP) with optical density >6 were placed between 
the microscope objective and a Pentamax 512-EFT/1EIA intensified charge-coupled device 
camera (ICCD, Princeton Instruments, Princeton, NJ, USA). The ICCD collected images 
with 30 ms exposure time at 2 Hz. The laser beam was chopped synchronously to the ICCD 
image collection rate with a Uniblitz mechanical shutter (LS2Z2, Vincent Associates, 
Rochester, NY, USA) and a driver (model T132, Vincent Associates) to reduce 
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photobleaching. A transmission grating with 70 grooves/mm (Edmund) was mounted in front 
of the ICCD camera to disperse fluorescence light from the molecules. The distance between 
the transmission grating and the ICCD was set to be 4 cm so that the zeroth-order and first-
order images of the 75 µm capillary could not overlap each other. 
Electrophoresis conditions.   The capillary was equilibrated with 0.25% C16E6 in 50 mM 
Gly-Gly solution (pH 8.2) for 15 min before use. The entire capillary was filled with sample 
solution with a syringe 5 min before irradiation by the excitation beam. Before each 
electrophoresis experiment, the heights of the buffer reservoirs were adjusted while 
molecular movement was monitored until no hydrodynamic flow existed in the capillary. 
Electric field, 1 kV/27.0 cm d.c., was applied with a Spellman high-voltage d.c. supply 
(Hauppauge, NY, USA). Data collection started 10 s after applying voltage. Between 
electrophoresis experiments, the capillary was washed with 0.25% C16E6 in Gly-Gly 
solution for 5 min.  
Results and Discussion 
Fluorescence imaging with transmission grating.   A fluorescence image from single DNA 
molecules in a capillary dispersed with the transmission grating is shown in Figure 2. The 
capillary was filled with a 1:1 mixture of YOYO-I-labeled Lambda DNA and POPO-III-
labeled Lambda DNA, both dissolved in 0.25% (w/w) C16E6 in 50 mM Gly-Gly buffer (pH 
8.2). Since POPO-III has an absorption maximum at 534 nm and has an efficiency of 26% at 
488 nm, POPO-III labeled DNA was not as bright as YOYO-I-labeled DNA that has an 
absorption maximum at 491 nm. With the distance of 4 cm between the transmission grating 
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and the ICCD, the non-dispersed zeroth-order image (left half) of the 75 µm capillary is 
imaged simultaneously with the dispersed first-order image (right half).  
The zeroth-order image is identical to that without transmission grating and can be used to 
calculate the mobility of individual DNA in the sieving matrix under electric field, just as in 
capillary gel electrophoresis. The zeroth-order capillary image was also used as a reference 
point to determine the dispersion distance between zeroth-order and first-order images. The 
emission maximum at 509 nm for YOYO-I and 570 nm for POPO-III resulted in dispersion 
distances of 1.425 mm for YOYO-I and 1.597 mm for POPO-III at this setting. Counting the 
number of pixels between the highest intensity pixels in the zeroth-order and corresponding 
first-order images allows the molecules to be distinguished from each other. 
DNA fragments after restriction enzyme reaction.   M13KE is a derivative of M13mp19 
and is different from M13mp18 by 26 bp. This small difference, however, creates different 
cutting sites for Acc65 I enzyme. BsmI cuts both at the same location to open the circular 
DNAs. As a result, M13KE cleaves into 7088 and 135 bp fragments, while M13mp18 DNA 
gives 4497 and 2752 bp fragments after cutting with Acc65I and BsmI restriction enzymes. 
These two DNA mimic a situation with normal DNA and a DNA with mutation caused by 
disease. 
Electrophoretic and spectroscopic data.   Figure 3 is a histogram of mobility of POPO-III-
labeled  M13KE and YOYO-I-labeled M13mp18 when the laser power is not high enough to 
provide adequate S/N ratio. The low S/N condition provides a stringent test of our 
discrimination scheme. The low laser power is required to avoid photobleaching over the 
series of successive images. The x-axis is the number of pixels traveled by the molecules in 1 
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second and the y-axis is the number of molecules. Picking molecules in these movies and 
calculation of their mobilities were done with the in-house software described in the image 
analysis section. Only the zeroth-order image area was subjected to the calculation of 
mobilities. Since the smallest DNA fragment that can be seen in this setup is ~800 bp18, the 
135 bp fragment from M13KE is not shown. As shown in Figure 3, the mobility differences 
found for 7088 bp M13KE and 4497 bp and 2752 bp M13mp18 were not distinct. With S/N 
= 2, the 2752 bp fragments were not picked up by the software. Table 1 shows that lower S/N 
from the less efficient emitter, POPO-III-labeled M13KE, resulted in a broad range of 
measured mobilities (with a standard deviation of almost 50%), which even covers the entire 
M13mp18 mobility region. So, it is not possible to identify molecules simply by mobility. 
Figure 4 is the wavelength dispersion distribution of POPO-III-labeled M13KE and YOYO-
I-labeled M13mp18. Higher laser powers can be used since only one image is required for 
spectral determination. From Table 1, the average dispersion of POPO-III is 87.9 pixels with 
a standard deviation of 2.16 and that of YOYO-I is 79.5 pixels with a standard deviation of 
1.78. The difference between the two averages is 8.43, which is 4.3 times the average of the 
two standard deviations. With more than four times the standard deviation, the two peaks are 
>99% separated from each other19. In other words, when DNA molecules are labeled with 
different dye colors, their identification can be done with greater than 99% accuracy. 
 
II. Single molecule detection of mRNA with 
fluorescence resonance energy transfer (FRET) 
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Experimental Section 
Reagents.    Nuclease-free water (Ambion, Austin, TX) was used for the preparation of all 
reagents. Digoxigenin-labeled human actin RNA probe (588 nt) was purchased from Roche 
(Indianapolis, IN) and labeled using a Ulysis Alexa Fluor 488 nucleic acid labeling kit 
(Molecular Probes). Human beta-actin cDNA  was prepared by PCR amplification using a 
Human beta-Actin Control Amplimer Set (BD Biosciences Clontech, Palo Alto, CA) and 
SuperTaq Plus polymerase (Ambion, Austin, TX). The positive control in the set was used as 
a template. The resulting size (~800 bp) and concentration (0.1µg/ul) was estimated from the 
agarose gel electrophoresis result. The PCR product went through a cleaning procedure using 
a Qiaquick PCR purification kit (Qiagen, Valencia, CA) and ethanol precipitation. Ulysis 
Alexa Fluor 532 (Molecular Probes) was used to label cDNA.  The labeling reaction for 
Alexa Fluor 488 was carried out according to the manufacturer’s instructions. For cDNA 
labeling, five times higher amount of dye was used along with a longer reaction time (~30 
min) at 80 oC than that suggested in the manual.   
 After the labeling reaction, the samples were further cleaned with a Qiaquick PCR 
purification kit one more time to eliminate excess labeling reagents. Assuming 100% yield 
for every cleaning and precipitation step, the concentration of the samples was 20 µg/ml for 
cDNA and 5 µg/ml for mRNA after the final clean-up procedure.  For single component 
experiments, cDNA was diluted 5000-fold and mRNA 100-fold. 
The hybridization reaction mixture was prepared with 10 µl cDNA and 20 µl mRNA mixed 
with 100 µl DIG Easy Hyb solution (Roche, Indianapolis, IN). The mixture was kept at 95 oC 
for 10 min for denaturation and 50 oC for 16 h for hybridization. The hybrid sample was 
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diluted 2 ×104 times with Nuclease-free water before imaging. For the control sample, the 
same concentration mixture of mRNA and cDNA as in the hybrid sample was prepared in 
DIG Easy Hyb solution and did not undergo hybridization steps.  
Bio-matrix preparation.   Two 5 ml tubes of whole blood were donated by a healthy donor. 
Plasma was prepared from one tube of blood, by applying centrifugation at ~28,800 g to 
separate blood cells from plasma. Half of the plasma was photobleached under a UV lamp 
overnight. Whole blood and plasma were diluted with deionized water just prior to mixing 
with the mRNA-cDNA hybrid samples, and the mixture was further diluted with deionized 
water. 
Instrumental setup.   The instrument setup is similar to that used in previous research16,17.  
A 30 cm long 75 µm i.d. and 365 µm o.d. square capillary was filled with sample before the 
image collection was started. A 25 mW 488 nm Ar-ion laser beam was focused with a 2.5 
focal length cylinder lens and illuminated from a side of the capillary.  
Fluorescence emission was collected at right angles to the excitation beam by a Zeiss 20× 
Fluar (0.75 NA) microscope objective connected to an intensified CCD (ICCD, Princeton 
Instruments, Princeton, NJ). A transmission grating of 70 grooves/mm (Edmund Industrial 
Optics, Barrington, NJ) was placed ~3 cm before the CCD in the collection beam path to split 
the light from samples into zero- and first-order images. The ICCD collected images with a 
150-ms exposure for the cDNA and hybrid sample and 100 ms for mRNA, both at 2 Hz.   
Results and Discussion 
Table 2 shows the average dispersion distance and relative fluorescence intensity of three 
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species imaged in this study. With ~3 cm distance between the transmission grating and 
ICCD, the dispersion of fluorescence from samplse between zero- and first-order images 
were 64.6, 68.7, and 68.2 pixels for mRNA with Alexa Fluor 488, cDNA with Alexa Fluor 
532, and hybrid, respectively. Figure 5 shows single molecule images of three species in a 
capillary. At the imaging condition of cDNA and hybrid with 150 ms exposure of 25 mW 
laser power, mRNA labeled with Alexa Fluor 488 had signal saturation and was imaged with 
100 ms instead. Signals from hybrid and Alexa Fluor 532 labeled cDNA were weaker than 
that of mRNA and imaged at 150 ms exposure. cDNA molecules appeared very dim and it 
was hard to recognize them individually. With five times’ the excessive amount of Alexa 
Fluor 532 than suggested by the manufacturer, cDNA molecules were stained to be 
‘invisible’. With 488 nm excitation light, the fluorescence efficiency for Alexa Fluor 532 is 
lower than maximum, but it is also believed that over-labeling resulted in shorter distances 
between covalently-bound dye molecules and caused quenching. The importance of the 
invisible probe is that it does not contribute to the background fluorescence much and hence 
allows good signal-to-noise ratio even at high probe concentration. However, when the 
cDNA was denatured and hybridized to the mRNA target, energy transfer took place to 
enhance the fluorescence of Alexa Fluor 532. Fluorescence from the hybrid was higher than 
that from cDNA by 2 to 2.5 times. The concentration used for single species movies was 
higher than the starting material concentration for the hybrid; 100 times for mRNA and 10 
times for cDNA. For the control experiment, mRNA was mixed with cDNA at the same ratio 
as in the hybrid, but without the hybridization process. Overall, a smaller number of 
molecules appeared than in the hybrid movie, and their dispersion distance was ~ 65 pixels,  
indicating that they are all mRNA molecules. There was no molecule with ~ 68 pixel 
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dispersion distance that has comparable intensity with hybrids found in the control movie. 
Figure 6 shows an overlaid histogram of three species. The difference in dispersion distances 
between  Alexa Fluor 488 labeled mRNA and the hybrid is 3.6 pixels and it is 2.53 times 
average standard deviation, which should mean more than 98.8%19 of molecules can be 
identified from each other in this system.   
The hybrid was further imaged in the presence of bodily fluid to estimate effects of crude 
sample preparation. Table 3 shows the maximum percentage of whole blood, plasma and 
saliva contents, and their signal and noise levels.  
Employing deionized water to dilute blood and plasma helped rupture the blood cells by 
creating hypotonic conditions. To minimize possible destruction of target with enzymes in 
bio-matrices, the hybrid was added right before imaging. It took no more than 1.5 min from 
the addition of hybrid to bio-matrix to the start of a movie.  Within the time period of making 
a movie (~20 sec,  40 frames/movie with 2 Hz imaging frequency), the loss of sample was 
not noticeable.  With the detection procedure within 2 min, it was not necessary to deactivate 
or eliminate nucleases in bio-matrices. If an adequate labeling reaction is employed and can 
be completed before losing the target dramatically, the whole assay can be done without 
complicated and precautious purification steps.  
With fluorescence from protein and blood cell materials, the background level was raised in 
the presence of these bio-matrices (Figure 7). Whole blood and unbleached plasma allowed 
the hybrid’s imaging with their contents of up to 8%. When plasma was photobleached 
overnight under a UV lamp to lower auto-fluorescence, our detection system could tolerate 
 
 
 22
up to 50% of its content to image beta-actin mRNA-cDNA hybrid.  Saliva could be present 
to 50%, but it contained bright particles that could be mistakable for hybrids in monotonous 
imaging. The dispersion distance of this particle was 63 pixels, which indicated it did not 
have Alexa Fluor 488 or Alexa Fluor 532.  They were thought to be cheek cells or cell debris 
from the oral cavity.  
Conclusions 
Single molecule DNA was imaged and identified in a thin capillary, using two criteria: 
electrophoretic mobility and fluorescence spectrum. In the identification of molecules with 
electrophoretic mobility, molecules were observed in three consecutive frames and the 
mobility information was obtained before the sample was separated as in conventional bulk 
capillary electrophoresis. Multiple fluorescence dyes were used to add spectroscopic 
information of the molecules. The fluorescence spectrum of individual DNA molecules was 
recorded while it passed through the detection window during electophoresis. No 
complicated instrumental addition was necessary. A transmission grating inserted in the 
fluorescence collection pathway dispersed the light from DNA molecules which appeared in 
part of the frame of the image collected. It took only one frame to obtain spectrum from each 
molecule with this system, and high laser power could be used to extract all available 
photons out of the molecules. With conditions where photobleaching of dyes is of concern 
and electrophoretic mobility measurements are limited by it, spectral information can be 
added to identify molecules with >98.8% accuracy.  
Hybridization of fluorescently labeled probe to target mRNA was performed and detected in 
the instrument set-up. Beta-actin mRNA was stained with shorter wavelength emitting dye 
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(Alexa Fluor 488) and probe cDNA was stained with longer wavelength Alexa Fluor 532. 
The probe cDNA was deliberately over-labeled to give out the least fluorescence with the 
detection condition. When proper hybridization takes place, energy from the Alexa Fluor 488 
(donor) transferred to the Alexa Fluor 532 molecule in probe strand (acceptor) and the hybrid 
molecule emitted acceptor dye fluorescence with enhanced intensity. The negative control 
showed no molecule with Alexa Fluor 532 emission.  
The beta-actin mRNA-cDNA hybrid was further imaged with bio-matrices added to the 
sample. Whole blood, blood plasma, and saliva ware tested. Up to 8% for whole blood and 
plasma, and up to 50% of photobleached plasma and saliva was tolerated before the signal-
to-noise ratio dropped below 3. Bright light scattering from impurities such as cells or cell 
debris could be ruled out because its spectrum differed from the target molecules’.  
Our strategy of single molecule nucleic acid detection provided a fast and accurate way to 
identify individual analytes. Taking less than a second to make a frame of a movie of  the 
target molecules, along with the presence of many molecules in one frame, it provides a 
high-throughput method to screen DNA more efficiently. 
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Figure 1. Images of single molecules passing through the observation region in a 75µm 
capillary under electric field in three consecutive frames of a movie.  
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Figure 2. Fluorescence emission from single molecules dispersed with a 70 grooves/mm 
transmission grating. 1:1 mixture of YOYO-I-labeled lambda DNA and POPO-III-labeled 
lambda DNA were filled in a 75-µm square capillary. Left, undispersed zeroth-order image. 
Each spot corresponds to one molecule. Right, dispersed first-order image spaced from the  
zero-order according to the wavelength. Each horizontal streak corresponds to a dispersed 
spectrum. 
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Figure 3. Histograms of DNA mobilities for POPO-III-labeled M13KE restriction enzyme 
digest and YOYO-I-labeled M13mp18 restriction enzyme digest. 
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Table 1. Discrimination between DNA by electrophoresis and by spectroscopy 
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Figure 4. Distribution of fluorescence maxima from POPO-III-labeled M13KE (7088 bp) 
and YOYO-I-labeled M13mp18 (4497 and 2752 bp) fragments. 
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Table 2. Average dispersion distance and relative fluorescence signal intensity 
 
  Alexa Fluor 488 labeled mRNA 
Alexa Fluor 532 
labeled cDNA Hybrid 
Average dispersion 
distance (pixels) 64.6 68.7 68.2 
Standard deviation 
(pixels) 1.30 2.88 1.56 
Relative signal 
intensity 6 1 2 
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Figure 5. Single molecule images of mRNA, cDNA, and hybrids (A) mRNA stained with 
Alexa Fluor 488, dispersion distance 65 pixels (B) cDNA stained with Alexa Fluor 532, 
dispersion distance 68 pixels (C) Control (RNA mixed with cDNA without hybridization) 
dispersion distance 66 pixels (mRNA). There was no molecule with ~ 68 pixel dispersion (D) 
Hybrid, dispersion distance 68-69 pixels. Left and right images are the same, with only 
different contrast settings to clearly visualize the molecules. 
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Figure 6. Overlayed histogram of three individual samples. The mRNA and cDNA/hybrid 
peaks are separated more than 98.8%, with a difference of the average dispersion distance of 
3.6 pixels. This difference is 2.53 times of the average standard deviation.
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Table 3. Signal and noise level of hybrid molecule images in the presence of bio-matrices at 
their optimal exposure 
 
first order BackgroundLevel 
Bright spot 
signal 
Exposure time 
(ms) 
8% bleached 
plasma 800 2000 100 
50% bleached 
plasma 2300 3700 70 
8% unbleached 
plasma 1600 2700 100 
8% whole blood 1800 2900 100 
50% Saliva 2000 3500 150 
water 500 1500 100 
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Figure 7. Single molecule images in added bio-matrices (A) 8% photobleached plasma (B) 
50% photobleached plasma (C) 8% whole blood (D) 50% saliva (E) A particle in saliva, 63 
pixels in separation. 
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CHAPTER 3. QUANTITATIVE SINGLE MOLECULE SCREENING 
OF HUMAN PAPILLOMA VIRAL DNA*1
 
Introduction 
Targeting DNA abnormalities has been one of the most popular strategies in clinical 
screening. Many diseases such as virus/bacteria infections, hereditary genetic problems, and 
acquired mutations can be detected with DNA identification. However, compared to the size 
of the human genome, the amount of target abnormality is usually very small. The human 
genome consists of 3 billion base pairs of DNA and for mutation that can cause diseases such 
as cancer, it can be one nucleotide difference or several copies of certain genes. For inherited 
mutations, its copy number in a cell is only one or two, while in acquired mutations the 
number is even lower; generally, by the time the patient is diagnosed with the disease, less 
than 50% of cells possess the mutation1. The virus inserts part of its genome into the human’s 
and use the human cell as a factory to make many replicas of itself, so the viral load in cells 
varies according to the stages of its infection.  However, for an early stage which is often 
used for an early diagnosis, the viral DNA in a cell should be less than 103 copies 2. To be an 
effective analytical method in clinical screening, one must have high selectivity as well as 
sensitivity. A strategy to make the target stand out with less false positives or background is 
required. This can be achieved with reinforced identification criteria for targets, getting rid of 
                                                 
∗ Reprinted in part with permission from Analytical Chemistry, 2006, 78, 6490-6496. 
Copyright (2006) American Chemical Society 
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non-target species through washing, or both. A combination of discrimination methods such 
as multiple probes or colors for labeling can be employed as reinforced criteria.  
In this study, small and hence invisible probes were used to hybridize and probe a 800 bp 
part of the target DNA. A second color dye was later introduced to ensure the identification 
of the target and reduce false positives. In another strategy, a solid substrate was used to 
capture the target molecules. This heterogeneous hybridization provides many advantages 
such as washing and reducing non-target molecules, as well as 100% detection efficiency.  
To test the applicability and performance of the single molecule imaging technique in real 
clinical samples, a study of human papillomavirus (HPV) and cervical cancer was carried out. 
Cervical cancer is the second most common cancer among woman with over 50% mortality 
rate3,4, killing more than 300,000 women per year. HPV is considered to be the primary cause 
of this cancer. Although this virus is very common and generally suppressed by the body’s 
immune system before it causes problems, certain high-risk subtypes of HPV such as HPV-
16 and HPV-18 can cause cell changes that may develop into cancer.  
The major reason for cervical cancer’s high mortality rate is that it does not show early-
warning symptoms or physical changes until it is very advanced.  Early detection of HPV 
could decrease the incidence of cervical cancer and increase the curability. Although the 
threshold of the viral load to the cancer stage is not exactly known, it has been established 
that there is a positive relationship between viral load and cervical cancer risk5,6. For early 
detection, high sensitivity is the key. Currently, the simple, inexpensive Papanicolaou smear 
(Pap smear) screening is the most widely used method. It certainly helps in reducing the 
incidence of cervical cancer, but it suffers from a significant false-negative rate of 20-40%7 
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as a result of inherent screening errors8. HPV testing based on viral DNA detection has 
drawn increasing attention and been suggested as a supplement to the Pap test9,10. Several 
amplification-based technologies have been developed for viral nucleic acid screening11. 
We demonstrate a new quantitative single-molecule method for detecting HPV DNA without 
amplification. The assay is based on the hybridization between HPV DNA and fluorescently 
labeled complementary DNA probes. HPV type 16 was chosen to be our target DNA, which 
alone accounts for ~50% of the cancer cases12, among more than 100 types of HPV. The 
length of HPV-16 DNA is 7904 base pairs (bp), and its oncogene E6-E7, which is 800 bp in 
size, is expressed in all HPV-containing tumors and derived cell lines. This gene can be 
found in both episomal and integrated forms in human chromosomes of the cells it infects13, 
thereby making it suitable for recognition.  
In flow system experiments, the viral DNA was probed by eight 100-nt complementary 
single-stranded (ss)-DNA. The individual probe molecules have fluorescence intensities 
below the threshold at the detection condition for hybrid molecules. The identification 
criteria were further reinforced by adding a second color dye. The additional staining was 
done by simply mixing an intercalating dye to the hybrid, but it lowered false positives to 
zero. In surface hybridization experiments, the entire human genomic DNA containing HPV 
was stained and hybridized to probe molecules tethered on a glass surface. To minimize 
ambiguity from false positives, another probe was also added. In this dual-probe system, only 
the second probe was stained and detected. For both experiments, added criteria reduced 
false positives greatly without compromising the sensitivity too much. This technique not 
only allows the detection and quantification of viral DNA with a low detection limit but also 
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offers a universal approach to other DNA sequences by simply changing the sequence-
specific probes.  
 
1. Quantitative single molecule screening of HPV-16 DNA in flow system 
 
Experimental Section 
Sample preparation.   Eight 100-nt ss-DNA probes were designed according to the 
sequences of the E6/E7 region of HPV-16 from Genbank (K02718) (Table 1) and 
synthesized by Integrated DNA Technologies (Coralville, IA). The probes were labeled 
individually with a Ulysis Alexa Fluor 532 nucleic acid labeling kit (Molecular Probes, 
Eugene, OR) according to the manufacturer’s instructions. After the staining reaction, the 
probes were submitted to a cleanup procedure with micro biospin columns (Bio-Rad 
Laboratories, Philadelphia, PA) to eliminate excess labeling reagents. All eight probes were 
mixed together for a subsequent hybridization step.  
In hybridization samples, the total amount of HPV-16 DNA (Maxim Biotech, San Francisco, 
CA) and female human genomic DNA (Promega, Madison, IL) was kept at 1 µg, while the 
ratio of them was varied to achieve a series of HPV-16 contents from 10-4 to 10%. The probe 
solution was mixed with the DNA so that the concentration of each probe was 8 times that of 
HPV-16 DNA. Finally, hybridization buffer (Maxim Biotech) was added to make a total 
volume of 30 µL. The samples were kept at 95 °C for 10 min for denaturation and at 42 °C 
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overnight for hybridization in a thermal cycler (GeneAmp PCR System 9700, Applied 
Biosystems, Foster City, CA). The hybridization samples were diluted with nuclease-free 
water (Ambion) to proper concentrations right before imaging (see Table 2). In dual-color 
detection, the samples were further labeled with YOYO-3 (Molecular Probes) at a ratio of 
one dye molecule per five bases.  
Cell line extracts.   Cervical cancer-derived cell lines CaSki and SiHa were purchased from 
ATCC (Manassas, VA). Normal Pap test specimens were donated by a healthy adult female. 
DNA from these specimens were extracted by the DNeasy tissue kit (Qiagen, Valencia, CA) 
and used without further purification. The DNA extraction yield is ~80% according to the 
manufacturer’s handbook. The DNA concentration was calculated from UV absorption at 
260 nm. The amount of extracted DNA from each Pap sample was 8 µg. 
Imaging System.   The imaging system was similar to the previous apparatus used in our 
group14,15, with some modifications (Figure 1). A 532-nm solid-state continuous-wave laser 
(45 mW, µ-Green model 4611, Uniphase, San Jose, CA) was used as an excitation source. A 
Uniblitz mechanical shutter (model LS2Z2, Vincent Associates, Rochester, NY) and a driver 
(model T132, Vincent Associates) were synchronized to the Pentamax 512-EFT/1EIA 
intensified charge-coupled device (ICCD) camera (Princeton Instruments, Princeton, NJ). 
The shutter allowed the laser beam to pass through only when the ICCD was on to reduce 
photobleaching. After the mechanical shutter, the laser beam was expanded by the first 
cylindrical lens (focal length, 200 mm; Thorlabs, Newton, NJ) in the Y-direction. The 
expanded beam was then focused into the capillary at normal angle as a thin sheet by the 
second cylindrical lens (focal length, 25 mm; Edmund Industrial Optics, Barrington, NJ).  
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The image of the laser focusing plane is schematically shown in the enlarged part in Figure 1. 
Only molecules inside the laser focusing plane could be excited and detected. The 
illuminated volume was ~0.2 nL, implying a detection efficiency of 13% considering the 
illuminated portion compared to the total thickness of the capillary bore. Hybridization 
samples were injected into a 30-cm-long square capillary (75 µm i.d., 365 µm o.d.; 
Polymicro Technologies, Phoenix, AZ), and the flow was driven hydrodynamically.  
Fluorescence from single molecules was collected by a Zeiss 20×/0.75 NA Plan-Apochromat 
microscope objective lens. A 532-nm, long-pass edge filter (Semrock, Rochester, NY) and a 
532-nm holographic notch filter (OD >6, Kaiser Optical, Ann Arbor, MI) were placed 
between the objective lens and the ICCD to cut off scattering from the excitation beam. A 
transmission grating with 70 grooves/mm (Edmund) was mounted in front of the ICCD 
camera to disperse fluorescence collected from the molecules. The distance between the 
transmission grating and the ICCD was set to be 6.5 cm so that the zeroth-order and first-
order images of the 75-µm-i.d. capillary would not overlap each other. The sampling 
frequency was 2 Hz, with the shutter driver set to 40-ms exposure and 460-ms delay. Images 
were obtained with WinView software provided by Princeton Instruments. 
Results and Discussion 
Single-color detection.   The eight oligo nucleotide probes aimed for E6/E7 genes of HPV 
were hybridized and imaged with the single molecule detection setup shown in Figure 1. The 
smallest DNA fragment size to be imaged with this setup is ~400 nt, so the individual probe 
does not appear as a molecule in the movies. For a meaningful quantitative comparison, the 
imaged volume was kept constant from run to run. Since the volume probed per detection 
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experiment (per movie) was proportional to the flow rate which was driven by hydrodynamic 
force, the heights of the sample reservoirs at the two ends of the capillary were fixed to 
ensure reproducibility. As shown in Figure 1, the sample volume of each frame is 75 × 75 × 
300 µm3, which is 1.7 nL. To make sure that the spots are molecules instead of random noise 
bursts of the ICCD, the molecules were tracked for five consecutive frames. A total of 1.7 nL 
of liquid flowed through the capillary and was imaged in five frames. With a 7500-frame 
movie, the total volume that flowed through the detection area was 2.6 µL. 
To evaluate quantification, HPV-16 DNA was added to commercial human genomic DNA. 
The total amount of viral and human genomic DNA in a vial was kept constant, while the 
ratio between them was varied to achieve a series of HPV-16 percentages from 0 to 10% (7 × 
105 copy/cell). After hybridization, the samples were diluted to suitable concentrations for 
counting individual molecules. The dilution factor for each sample was designed (Table 2) to 
make sure that molecules did not overlap with each other in the high-concentration samples, 
and the number of hybridized molecules was higher than three times that of false-positive 
counts in the low-concentration samples. A flow system was selected to allow screening of a 
much larger volume of sample than that within the detection window. Note that only a small 
fraction of the total sample passed through the observation region per count period. After the 
movies were recorded, the molecules were counted manually while fast-forwarding the 
movies. The numbers were further normalized considering the movie length and dilution 
factor. Figure 2B shows a good linear relationship over a range of 6 orders of magnitude 
between HPV-16 DNA percentage and the number of molecules detected.  At low 
concentrations, the precision is limited by counting statistics.  
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To test the compatibility of the current Pap test sampling method with this assay, we 
extracted DNA from normal Pap smear specimens. About 8 µg of total DNA could be 
obtained from each specimen. Viral DNA was added to the extracted DNA matrix in the 
same way as in the commercial human genomic DNA experiments (Table 2). In Figure 2B, 
the red data points for the extracted DNA matched well with the blue ones for the standard 
samples. The results also show that the background levels of the two matrices were similar, 
indicating that DNA extracts from Pap test specimens did not have biological impurities that 
would interfere with single-molecule detection.  
This single-molecule assay was further tested for cell lines with known viral load. According 
to the supplier, American Type Culture Collection (ATCC), the HPV-16 viral loads in 
cervical cancer-derived cell lines CaSki and SiHa are ~600 and 1-2 copies/cell, respectively. 
The average number of molecules detected with our system was 8200 molecules for CaSki 
and 49 for SiHa per experiment. The detected numbers were converted to the HPV-16 DNA 
percentages based on the flow rate and the sample volume, and the DNA content of each cell 
is calculated by dividing the extracted DNA amount by the cell population. The calculated 
viral loads were 540 copies/cell for CaSki and 2.4 copies/cell for SiHa. The agreement with 
the numbers from ATCC means that this quantitative assay is well-behaved. 
For the false positives, the number of molecules measured for the 0% HPV-16 DNA sample 
(inset of Figure 2B), there are three possible sources: aggregation of unbound probes, non-
sequence-specific hybridization with human genomic DNA, and random noise of the ICCD 
camera. The first factor could be neglected as no counts were found in control experiments 
that contained probes only. Cross-hybridization could be minimized by optimization of 
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hybridization conditions, such as temperature and ionic strength of solution. When two 
random noise spikes accidentally showed up in the images with reasonable dispersion 
distance, they would be counted as false positives as well. These could be greatly reduced by 
the dual-color detection mode described below. The ratio of the number of detected HPV-16 
DNA molecules to that of false positives is the signal-to-noise ratio (S/N). The detection 
limit of HPV-16 DNA is 0.0001% (0.7 copy/cell) when S/N equals three. This sensitivity is 
extremely high among the quantitative assays of nucleic acids. Moreover, this was achieved 
without amplification. 
Dual-color detection. A second dye was added to the single-color detection scheme to 
improve the selectivity. Dual-color detection involves three spots in the movie (one zeroth-
order, and two first order spots) for identification, and hence has less possibility of false 
positives from ICCD noise. The chances of three random noise spikes accidentally appearing 
with the correct dispersion distance is negligible.  
The intercalating dye YOYO-3 (612/631) was added after hybridization of Alexa Fluor 532-
labeled probes to the target so that it stains the whole genome. YOYO-3 was chosen as the 
second dye according to three criteria. First, it has emission maximum at 631 nm, which is 
easily distinguished from that of Alexa Fluor 532 (555 nm). Second, its absorption maximum 
(612 nm) is far away from the excitation wavelength (532 nm) so that it is very dim without 
energy transfer from Alexa Fluor 532. Third, its fluorescent intensity is comparable to the 
Alexa Fluor 532 donor when partial FRET occurs. These features allowed us to identify the 
dual-color molecules conveniently.   
Figure 3A shows the hybridized molecules labeled with YOYO-3 as an enhancement to the 
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single-color system. When excited by a 532-nm laser, fluorescence from both Alexa Fluor 
532 and YOYO-3 were detected. A typical dual-color image of pure HPV-16 DNA 
hybridization sample is shown in Figure 3B. The left peak in the first-order image 
corresponds to the emission of Alexa Fluor 532 at 555 nm while the right peak corresponds 
to the emission of YOYO-3 at 631 nm. The average dispersion of Alexa Fluor 532 was 106.6 
± 0.9 pixels and that of YOYO-3 was 121.8 ± 1.2 pixels. The difference between the two 
averages was 15.2 pixels, which was 14.4 times the average of the two standard deviations. 
That is, the two peaks are clearly separated from each other. The statistical information was 
collected in the same way as for single-color detection. There were 90 molecules counted in 
the experiment, in which 77 molecules had two peaks and 13 molecules had one. All of the 
single-color molecules were associated with the dispersion distance of YOYO-3, which 
represented the target DNA bound with too small of a number of probes. The hybrids with at 
least five probes clearly appeared as bright spots in our setup (data not shown). 
 In the presence of bulky human genomic DNA as the matrix for two-color DNA detection, 
YOYO-3 made them appear as bright single-color molecules. The background level was 
increased, and it was not practical to seek out the dual-color hybridized molecules among the 
single-color matrix, especially when the HPV-16 DNA content was low. This problem 
resulted in poor sensitivity, and the detection limit was only 1% (7 × 103 copies/cell) HPV-16 
DNA. To solve this problem, we used a restriction endonuclease to digest human genomic 
DNA into small pieces, with an average length of 4 kb. HindIII worked well for cutting 
human genomic DNA while preserving the E6-E7 region of HPV-16 DNA uncut. There was 
1 order of magnitude improvement in detection limit, that is, down to 0.1% (7 × 102 
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copies/cell) with this digestion step. In the negative control experiment, where the sample 
contained everything except the target DNA, no dual-color signal was detected. It is worth 
pointing out that although the sensitivity could not compete with single-color detection, the 
lack of false positives was a significant advantage for dual-color detection. 
 
2. Quantitative single molecule screening of HPV-16 DNA using surface hybridization 
 
Experimental Section 
Slide pre-treatment.   Custom-made cover glass coated with poly-L-lysine (22 × 40 mm) 
was purchased from TeleChem International (Sunnyvale, CA). The surface probe was 100-
nt oligo nucleotide of 661-760th base region of HPV-16, in E7 gene (IDT, Corralville, IA).  
The probe was dissolved in 10 mM Gly-Gly solution (pH 8.2) to a concentration of 0.02 
µg/µl.  5µl of this solution was pipetted onto a poly-L-lysine coated cover glass (“Slide”), 
sandwiched with clean 22 × 22 mm cover glass, and kept at room temperature for 1 h. The 
top cover glass was removed before UV-crosslinking in StrataLinker UV-crosslinker 
(Stratagene, La Jolla, CA) at 150 mJ. The slides were dipped in deionized water 2-3 times 
and dried under a nitrogen stream. To deactivate unused functional groups on poly-L-lysine, 
the slides were immersed in a solution of 3 g succinic anhydride (Fluka) dissolved in 170 
ml 1-methyl-2-pyrrolidinone (Aldrich), buffered with 7.5ml 1M sodium borate (pH 8.3, 
Fluka) for 20 min. After a gentle washing in 200 ml deionized water for 5 min, slides were 
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immersed in 95 oC deionized water for 2 min, dipped 5-10 times in 95% ethanol and blow-
dried with nitrogen.  
DNA preparation.   HPV-16 genomic DNA (Maxim Biotech) and human female genomic 
DNA (Promega) was digested with three restriction enzymes: HaeIII, NcoI, and BstNI 
(New England Biolabs, Ipswich, MA). After digestion, both DNA were cleaned with a 
QiaQuick PCR purification kit (Qiagen) and redissolved in 10 mM Tris-Cl. For the single-
probe detection experiment, both HPV and human genomic DNA were stained with a 
Ulysis Alexa Fluor 532 kit, and purified with a QiaQuick PCR purification kit. At the final 
elution step of purification, Maxim Bio Hybridization II solution (Maxim Biotech) was 
used to redissolve DNA. HPV DNA was added to the human genomic DNA according to 
the concentration ratios shown in Table 3.  
Second probe preparation for dual-probe detection.   For dual-probe detection, the 
second probe was made to accompany a 1 kbp DNA fragment stained with Alexa Fluor 532 
dye as a fluorescence tag. The 1 kbp tail sequence was from pBR322 vector, so that the 
sequence would not match either HPV or human genomic DNA. The probe molecules were 
synthesized by PCR, using one scorpion primer that has 50-nt HPV probing sequence on 
the 5’-end of the primer for clockwise PCR (Table 1, probing part is underlined) and one 
regular counter-clockwise primer for pBR322 vector (Table 1). These primers ware also 
custom-made by IDT.  SuperTaq PCR kit (Ambion) was used for PCR.  After purification 
with a QiaQuick PCR purification kit, the product was submitted to gel electrophoresis with 
2% agarose E-gels (Invitrogen). The main DNA band was excised and DNA was extracted 
with a QiaQuick gel extraction kit. After quantification with UV absorption measurement, 1 
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µg of probe was submitted to a labeling reaction with a Ulysis Alexa Fluor 532 kit. All 
DNA were dissolved in Corning Pronto! long oligo hybridization solution. Each slide was 
loaded with 70 µl solution containing 5 µg human genomic DNA, spiked HPV, and stained 
second probes.  
Cell line extracts.   Two cell lines with known HPV infection (CaSki, SiHa) and one 
normal cell line (C-33A) were purchased from ATCC, as described in the flow system 
experiment. The cells were directly submitted to DNA extraction using a DNeasy kit 
without culture. Obtained DNA was digested with three restriction enzymes, HaeIII, NcoI, 
and BstNI. After cutting, the DNA was purified with a QiaQuick PCR purification kit. For 
single-probe experiments, this cut DNA was stained with Ulysis Alexa Fluor 532 kit and 
purified. For dual-probe experiments, unstained DNA was added along with a second probe 
onto each slide. Each slide was loaded with DNA extracted from 106 cells and dissolved in 
70 µl Corning Pronto! long oligo hybridization solution.  
Loading, hybridization and washing.   At least 30 min before sample loading, the slide 
and hybridization chamber (Corning) were pre-heated to 55-60 °C. The sample mixture was 
kept at 95 °C for 10 min, and then at 72 °C until it was loaded on the slide. On each slide, a 
19 × 6 mm silicon gasket perfusion chamber (Molecular Probes) was added to 
accommodate the hybridization solution. For each slide, 5 µg of human genomic DNA and 
spiked HPV was loaded in 70 µl total volume. Slides with samples were enclosed in 
Corning Pronto! hybridization chambers, and kept in a 55 °C oven for ~16 h. After 
hybridization, the slides were submitted to a series of washing with wash solutions from a 
Corning Pronto! hybridization kit, following the manufacturer’s instruction. After the 
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washing, the slides were dried under a gentle nitrogen stream and kept in a dark box. Right 
before imaging, the slide was hydrated with 5 µl 10 mM Gly-Gly buffer (pH. 8.2) and 
covered with a clean 22 × 22 mm cover glass. 
Imaging system.   To image molecules on the glass surface, evanescent field layer 
illumination was used (Figure 4). The slide was located on top of a right-angle fused silica 
prism (Melles Griot, Carlsbad, CA), with emulsion oil in between. A 532-nm solid-state 
continuous wave laser (45 mW, µ-Green model 4611, Uniphase, San Jose, CA) was used 
again as the excitation source.  The laser was modulated with a Uniblitz mechanical shutter 
(model LS2Z2, Vincent Associates, Rochester, NY) and a driver (model T132, Vincent 
Associates), which were synchronized to the Pentamax 512-EFT/1EIA intensified charge-
coupled device (ICCD) camera (Princeton Instruments, Princeton, NJ). Fluorescence from 
individual hybridized molecules was collected by a Zeiss 100×/1.2 NA Plan-Neofluar 
microscope objective lens. Two 532-nm long-pass edge filters (Semrock, Rochester, NY) 
were placed between the objective lens and the ICCD to cut off scattering from the excitation 
beam. The sampling frequency was 2 Hz, with 20-ms exposure. Images were obtained with 
WinView software provided by Princeton Instruments. 
Results and Discussion 
Single-probe detection.  In this assay, both female human genomic DNA and HPV-16 DNA 
were stained with Alexa Fluor 532 dye. Since DNA fragments larger than 1 kbp are likely to 
precipitate out when stained with the dye, both DNA were cut with restriction enzymes. Nco 
I and Hae III cut near the E6/E7 gene of HPV-16 and make the target fragment 1001 bp in 
size. BstN I enzyme was used to chop up human genomic DNA smaller than 1 kbp, without 
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affecting the size of the target (Table 4). Figure 5 is a schematic diagram of two surface 
hybridization strategies. After overnight hybridization, the slide was washed, dried and 
submitted to imaging. Evanescent field illumination was used to excite surface-hybridized 
molecules. The incident laser beam angle was set to create a maximum evanescent field 
depth. With an oil type ×100/1.2 N.A microscope objective lens, the imaging area was 
0.0132 mm2. 
When the hybridization was carried out at 42 °C, non-specific adsorption of DNA on the 
surface was very high, making counting almost impossible. A higher temperature for 
hybridization (55 °C) helped reduce non-specific adsorption down to 128 ± 20.8 counts per 
frame, but could not eliminate it totally.  Further increase in temperature to 60 °C reduced the 
number somewhat, but also lowered counted numbers in the HPV sample, especially near the 
detection limit, making it undistinguishable from the background (data not shown).  
Figure 6 shows typical images of single probe hybridization. In the negative control sample 
(Fig. 6 A), non-specific adsorption was high, increasing the background signal. This non-
specific adsorption also caused large aggregation spots on the surface and a background 
signal different from frame to frame in a single movie. For image analysis, the background 
signal average and sigma value of each frame was obtained with WinView software and the 
display range of movie was set in between (average+2σ) and (average+5σ) during the 
counting.  
When the imaging area is 0.0132 mm2, the expected number of the target hybrid molecules 
was 60 for 10-4% HPV, 600 for 10-3% HPV and so on. Considering the net count (each 
concentration’s molecule count subtracted by the background count) compared to the 
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expected population in the imaging area, the hybridization efficiency of this assay is between 
50-60% in average for 10-4 - 10-3 % HPV samples (Table 5). The maximum number of 
molecules that can be imaged in a 512 × 512 pixel camera is 2500, so a 10-2% HPV content 
(70 copies/cell) sample should be virtually our high-end detection limit.  However, the actual 
molecule count increase slows dramatically after 10-3% HPV, and 10-2% HPV shows 398 ± 
101 counts, only 10% higher counts for 10-3% sample. The equilibrium hybridization 
isotherm is of Langmuir form, and in general cases it reflects the electrostatic penalty 
incurred because each hybridization event increases the charge of the probe layer16-18.  
Although many studies that involve surface hybridization such as microarray still claim good 
results with a linear dynamic range of two orders of magnitude, it is not wide enough, 
especially for viral DNA quantification where the target DNA amount can be higher than the 
inherited or acquired mutation – the HPV viral load can go as high as 103 copies/cell at the 
starting stage of cancer2. Reducing the background will be essential to widen the linear 
dynamic range.  
The average count in negative control is considered as background, and its standard deviation 
is noise. When the S/N ratio is 3, the detection limit is 10-4% HPV content (0.7 copy/cell), 
equal to that of the flow system. In molar concentration, this HPV content is ~16 fM in a 
loaded volume of 70 µl and at least 10 times lower detection limit than that of a conventional 
microarray.  
As in flow detection system experiments, cell line extracts with known HPV-16 contents 
were used with the single probe surface hybridization method. In each slide, DNA extract 
from 106 cells was loaded. A human cell contains 6 pg of DNA, and with ~80% yield of 
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extraction and staining procedures, the actual DNA load per slide is considered to be ~5 ug, 
the same as in purified commercial DNA experiments. The counted number of each cell line 
sample is shown in Table 6.  For SiHa cells, calculated copy number was ~0.7 copy/cell, 
which was slightly lower than the known value of 1-2 copies/cell. A normal cell line without 
HPV-16 (C-33A) showed the number counted per frame very close to that of negative control. 
The known viral contents for the CaSki cell line is ~600 copies/cell, and is beyond our high-
end detection limit. When the molecule number was counted, it was 393 ± 138 counts per 
frame, which is close to the saturation value of our system. 
Dual-probe detection.   Instead of staining the entire human genome and HPV, a second 
probe with a 1 kbp tail was added to the assay to lower down background caused by non-
specific adsorption (Figure 5B). The second probe has a 50 nt ‘probing’ part, which is 
complementary to the 121-170th base region of the HPV genome, located in the E6 gene. The 
surface probe targets the 661-760th base region of HPV, so there is ~490 nt gap between the 
two probes, as shown in Figure 7.  A 1 kbp tail is attached to the 3’ end of the probing part 
via two C-18 spacers. The tail was made by PCR amplifying a part of pBR322 DNA, 
between BamH I and Sty I restriction enzyme cutting sites. The PCR products were run with 
gel electophoresis, and the exact 1 kbp band was excised and extracted to ensure size 
uniformity. In dual-probe hybridization, only the second probe was stained with Alexa Fluor 
532 dye. An equal amount of the second probe was added to all samples (0.025 µg/slide), 
regardless of the HPV DNA contents. Extra care was used during the washing steps, and 
blow drying was omitted. Instead, slides sat for 30 minutes at room temperature.  
Figure 8 shows the frame captures from a hybrid detection movie. With a 1 kbp DNA tail 
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labeled with Alexa Fluor 532 dye, the signal from the target clearly stands out with a signal-
to-noise ratio  >10. The amount of DNA stained with fluorescent dye in dual-probe detection 
is 0.025 µg per slide and it is 1/200 of the stained DNA used in single-probe mode. 
Compared to single-probe experiment results, non-specific adsorption is far less (2.4 counts 
per frame). The average molecule counts for each concentration from 0.7 copy/cell to 7,000 
copies/cell are shown in Table 7. When plotted in a log-log relationship, the viral contents 
and the number of molecules counted in a frame have a linear relationship with a slope of 
0.4838 (Figure 9). The assay has nearly 4 orders of linear dynamic range, and when the 
average molecule count in negative control sample and standard deviation were considered as 
background and noise respectively, the detection limit of this assay is 2.36 copies/cell.  
It is thought that the hybridization of target molecules changes the surface environment, and 
causes deviations from the simple Langmuir isotherm. In dual probe hybridization mode, 
there are two methods that hybridization takes place in at the same time:  
(1) target + surface probe, and then second probe + target on the surface 
  (2) target + second probe, and then  this hybrid + surface probe. 
In scheme (2), it is similar to hybridization in the single probe experiment, except that the 
target is now 2 kbp hybridizing to the surface probe. In scheme (1), however, the target’s 
hybridization increases the surface charge density of that area, whose electrostatic repulsion 
reduces the second probe’s hybridization chance18. As a result, when both schemes take place 
simultaneously, the number of 3-component hybridization is lower than expected. At low 
target concentrations this effect can be neglected, but at high concentrations it becomes 
important.  
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Cell line extracts were also used with the dual-probe scheme, to test the performance with a 
real sample. In the same way as the single probe experiments, three cell line extracts were 
loaded on slides with 106 cells of DNA per slide concentration. The detected HPV contents 
for CaSki (600 copies/cell HPV-16), SiHa (1-2 copies/cell) and C-33A normal cell line 
experiments were calculated using the equation of the log-log plot (Figure 9) with average 
molecule counts from each movie. The result values were 815 copies/cell for CaSki and 1.22 
copies/cell for SiHa (Table 6). The molecule count for C-33A was 3.80 counts per frame, 
which falls within the range of the negative control (2.54±1.40 counts per frame). The actual 
average count for CaSki was lower than that of 700 copies/cell sample, but the calculated 
value with our experiment showed a slightly higher number. The viral content of the SiHa 
cell line was lower than the detection limit determined by the calibration curve (2.36 
copies/cell), but the counted number of 6.09 ± 3.25 counts per frame was slightly higher than 
that of the 10-4% sample and the calculated number is close to the known value. All three 
results showed good agreement with known viral loads and results from other assays of our 
flow system and single probe surface hybridization system.  
Although the performance of our surface hybridization method cannot be directly compared 
to that of conventional microarrays, where up to 105 genes can be analyzed in a single 
experiment, the detection limit and dynamic range of our surface experiments showed at least 
10 times improvement in both categories19.  The genomic DNA or cDNA labeling procedure 
that is often employed in microarrays involves amplification either by PCR (>1000×) or 
using random hexamer  primers (> 7-10×) . Since the amplification makes the original 
amount or ratio of the sequence in the cell meaningless, the sample set of DNA is usually run 
together with a control set without mutation to compare in microarray and the ratio between 
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their fluorescence intensities is obtained as data. With single molecule detection, the actual 
molecule count is obtained and it can be directly multiplied or divided with a dilution factor 
to obtain the target nucleic acid quantity in the original cell. Furthermore, without this 
amplification step, single molecule detection can provide a less error-prone result.  When a 
transmission grating is incorporated to recognize the spectrum of   individual molecules, 
multiple color dyes can be used to compare the target amounts from several cells from 
different origins, simultaneously. Application of single molecule assay and detection strategy 
can make conventional microarray an even more efficient and meaningful method to analyze 
genomes. 
Conclusions 
Four DNA screening systems have been tried, detected in a flow and on a surface, each with 
one and two probes. For the flow detection system with a one-color probe, the assay is 
sensitive with a detection limit of 0.7 copy/cell and has a wide linear dynamic range over 6 
orders of magnitude. For the surface hybridization method, detection limits were 0.7 
copies/cell and 2.4 copy/cell for single- and dual-probe modes, respectively, which is as 
sensitive as the flow system. With linear log-log relationship, the dual probe method had a 
linear dynamic range of 4 orders of magnitude. It is reliable in quantification since no 
amplification is involved. Although PCR methods have enabled detection at the level of 0.05 
copy/cell20, they are prone to false positives, with problems of contamination, enzyme 
inhibition and other concerns. 
The probe design is a key step in these methods. In flow detection experiments, the single 
unbound probes are invisible at the selected threshold but become visible when at least five 
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of them hybridized to the target. The digital counting approach avoids the need to remove the 
unbound probes or add quenchers after hybridization to decrease background. Dual-color 
detection could achieve zero false-positive counts, with unmistakable and distinct two-peak 
spectra only with target molecules. In surface hybridization experiments, the number of false 
positives was dramatically cut by avoiding staining of the entire genome and adding second 
probe with a fluorescent tail instead.  
For all four methods, the whole procedure involved little more than DNA extraction, 
hybridization, and imaging. Moreover, this technique can be directly coupled with current 
sampling methods such as Pap smears. Since this screening technology does not require other 
HPV-16 DNA specific features (e.g., antibodies) except for the probe sequence, it is readily 
applicable to any DNA detection and quantification by changing the probes. 
In comparison with photonburst detection21, imaging allows substantially higher throughput 
in molecule counting. Up to 2500 molecules can be screened in 20 ms. The transmission 
grating offers simple, accurate, and sensitive spectral analysis when compared to using 
multiple optical filters or multiple lasers. The detection efficiency of the flow system can be 
further increased to near 100% with radial focusing of molecules inside the capillary when an 
electric field is applied across the capillary along with hydrodynamic flow14. When a solid 
surface was used to capture target DNA, 100% detection efficiency is possible by scanning 
the sample area. Furthermore, the detection can be done later, with an absence of non-targets 
and excessive probes after washing.   
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Table 1. Probe sequences 
Flow system 
detection 
Fragment 1 
 
 
 
Fragment 2 
 
 
 
Fragment 3 
 
 
 
Fragment 4 
 
 
 
Fragment 5 
 
 
 
Fragment 6 
 
 
 
Fragment 7 
 
 
 
Fragment 8 
ttagtataaa agcagacatt ttatgcacca aaagagaact 
gcaatgtttc aggacccaca ggagcgaccc agaaagttac 
cacagttatg acagagctg 
 
caaacaacta tacatgatat aatattagaa tgtgtgtact 
gcaagcaaca gttactgcga cgtgaggtat atgactttgc 
ttttcgggat ttatgcatag 
 
tatatagaga tgggaatcca tatgctgtat gtgataaatg tttaaagttt 
tattctaaaa ttagtgagta tagacattat tgttatagtt tgtatggaac 
 
aacattagaa cagcaataca acaaaccgtt gtgtgatttg 
ttaattaggt gtattaactg tcaaaagcca ctgtgtcctg 
aagaaaagca aagacatctg 
 
gacaaaaagc aaagattcca taatataagg ggtcggtgga 
ccggtcgatg tatgtcttgt tgcagatcat caagaacacg 
tagagaaacc cagctgtaat 
 
catgcatgga gatacaccta cattgcatga atatatgtta gatttgcaac 
cagagacaac tgatctctac tgttatgagc aattaaatga 
cagctcagag 
 
gaggaggatg aaatagatgg tccagctgga caagcagaac 
cggacagagc ccattacaat attgtaacct tttgttgcaa gtgtgactct 
acgcttcggt 
 
tgtgcgtaca aagcacacac gtagacattc gtactttgga 
agacctgtta atgggcacac taggaattgt gtgccccatc 
tgttctcaga aaccataatc 
Suface Probe 
5'- GAG GAG GAT GAA ATA GAT GGT CCA GCT GGA CAA 
GCA GAA CCG GAC AGA GCC CAT TAC AAT ATT GTA 
ACC TTT TGT TGC AAG TGT GAC TCT ACG CTT CGG T -3' 
2nd probe 
Clock-wise  
PCR Primer 
5'- GGA GCG ACC CAG AAA GTT ACC ACA GTT ATG CAC 
AGA GCT GCA AAC AAC TA -(Spacer C-18)-(Spacer C-18)-
TAC TTG GAG CCA CTA TCG ACT ACG C -3' 
Surface 
hybridization 
2nd probe 
Counter- 
clock-wise  
PCR Primer 
5’-GCT GGA GAT GGC GGA CG-3’ 
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Figure 1. Schematic illustration of the experimental setup: laser, 532-nm continuous-wave 
solid-state laser; MS, mechanical shutter; CL1, cylindrical lens, FL) 200 mm; CL2, 
cylindrical lens, FL) 25 mm; SC, square capillary; O, objective lens, 20x/NA 0.75; F1, 532- 
nm long-pass edge filter; F2, 532-nm holographic notch filter; TG, transmission grating; 
ICCD, intensified CCD camera; PG-200, function generator for controlling the ICCD; PC, 
personal computer for data acquisition and analysis. The inset shows the excitation and 
detection regions. 
 
 
 62
Table 2. Contents of hybridization samples and the corresponding dilution factors for 
imaging   
 
 
 
 
 
 
 
 
 
a The values in parentheses are the dilution factors for the probes; e.g. for 5% HPV-16 DNA, 
the original probe solution was diluted 10 times and then 5 µL of the diluted probe solution 
was added into the sample. 
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Figure 2. Single-molecule detection of HPV-16 DNA in single-color mode. (A) Schematic 
diagram of single-color mode. After heat denaturing, HPV-16 DNA was hybridized to the 8 
complementary oligonucleotide probes labeled with Alexa Fluor 532. The 550-nm 
fluorescence images of the hybrids were recorded by ICCD camera when excited by 532-nm 
laser. (B) Standard curve of the quantification of HPV-16 DNA. Both axes are logarithmic 
scales. The blue points depict the averages over three experiments with commercial human 
genomic DNA, and the error bars are the standard deviations (Table 2) of these three sets; the 
red points are data from one experiment with extracted DNA from the Pap smear sample. 
The inset shows the number of counts in negative control and the low-concentration region. 
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Figure 3. Single-molecule detection of HPV-16 DNA in dual-color mode. (A) Schematic 
drawing of dual-color imaging. After heat denaturing, HPV-16 DNA was hybridized to the 
complementary oligonucleotide probes labeled with Alexa Fluor 532. The hybrids were then 
labeled with YOYO-3. Both 550- and 631-nm fluorescence images of the hybrids were 
recorded by the ICCD camera when excited by 532-nm laser. (B) Fluorescence images of 
two Alexa Fluor 532 + YOYO-3 colabeled probes/HPV-16 DNA hybrid molecule.  
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Table 3. Contents of hybridization mixtures loaded on a slide 
HPV-16 
DNA (µg) 
HPV-16 copy 
number per cell
HPV-16 
DNA 
Human genomic 
DNA  (µg) 
Volume loaded
(µL) 
5x10-3 700 0.1% 5 70 
5x10-4 70 0.01% 5 70 
5x10-5 7 0.001% 5 70 
5x10-6 0.7 0.0001% 5 70 
0 0 0 5 70 
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Figure 4. Schematic diagram of evanescent field layer illumination system: FP, fused silica 
right angle prism; EO, emulsion oil; CG, cover glass; PLL, poly-L-lysine coating; SP, sample 
layer of hybridized molecules on surface; EF, evanescent field layer; BF, buffer solution.
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Table 4. Restriction enzyme cutting sites for HPV-16 DNA 
Restriction 
enzyme NcoI HaeIII BstN I 
Recognition 
sequence C/CATGG GG/CC CC/WGG 
 
Cutting site in 
HPV-16 
genome 
(7,904bp) 
 
863/867 
 
1953/1953 
2591/2591 
2890/2890 
3400/3400 
4468/4468 
4530/4530 
5107/5107 
5661/5661 
5937/5937 
5992/5992 
6589/6589 
7062/7062 
7432/7432 
7766/7766 
 
4884/4885 
5529/5530 
6181/6182 
6865/6866 
6903/6904 
7429/7430 
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Figure 5. Two surface hybridization modes. (A) Single probe hybridization, (B) Dual probe 
hybridization. 
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Figure 6. Single molecule images of single probe surface hybridization (A) 0% HPV DNA, 
(B) 10-4% HPV DNA, (C) 10-3% HPV DNA, (D) 10-2% HPV DNA. Total amount of 5 µg 
human genomic DNA with added HPV-16 DNA was loaded on a glass slide that has 100nt 
oligo nucleotide probes on the surface. All slides were hybridized at 55 °C for 16 h. Display 
range: (Background Average+2σ) – (Background Average+5σ) 
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Table 5. Number of molecules observed in single probe hybridization assay 
 
 
 
0 % HPV DNA 
(Negative 
Control)) 
10-4 %HPV DNA
(0.7 copy/cell) 
10-3 %HPV DNA 
(7 copy/cell) 
10-2 %HPV DNA
 (70 copy/cell) 
Number 
counted 128 177 369 398 
Standard 
Deviation 20.8 19.3 77.0 101.4 
Net Count* 
(Expected 
number**) 
0 (0) 49 (60) 241 (600) 270 (6000) 
*Net Count = (Number counted in each concentration experiment) – (Number counted in 
Negative control) 
**Expected number = Number of molecules in one frame expected, when hybridization 
efficiency is 100% 
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Table  6. Average and standard deviation of counted molecules in cell-line extract 
hybridization, and calculated HPV-16 DNA contents per cell 
 Single probe hybridization Dual probe hybridization 
Cell Line CaSki (600/cell) 
SiHa 
(1-2/cell) 
C-33A 
(0/cell) 
CaSki 
(600/cell) 
SiHa 
(1-2/cell) 
C-33A 
(0/cell) 
Average 
count 393 177 128 117.3 6.08 3.80 
Std Dev 138 22.7 27.9 16.5 3.25 1.80 
Calculated 
HPV-16 
contents 
(copy/cell) 
≥ 70 0.7 
Less than 
detection 
limit 
(~ 0) 
815  
Less than 
detection 
limit 
( 1.22 )* 
Less than 
detection 
limit 
( 0.212)* 
 
*Calculated values using standard curve equation shown in Figure 9.
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Figure 7. (A) Location of probes, (B) HPV-16 DNA fragment properly hybridized with two 
probes.
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F D E 
 
 
Figure 8. Frame captures from dual probe hybridization detection movies. Each dot 
represents one probe molecule (second probe with 1 kbp tail), stained with Alexa Fluor 532 
dye. (A) 0% HPV DNA, (B) 10-4% HPV DNA, (C) 10-3% HPV DNA, (D) 10-2% HPV DNA, 
T (E) 10-1 % HPV DNA, (F) 1% HPV DNA. Display range: 67 – 4095.
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Table 7. Single molecule counts per a frame of a movie, average and standard deviation 
 
 
0 % HPV 
DNA 
(Negative 
Control) 
10-4 %HPV 
DNA 
(0.7 copy/cell)
10-3 %HPV 
DNA 
(7 copy/cell) 
10-2 %HPV 
DNA 
 (70 copy/cell)
10-1 %HPV 
DNA 
(700copy/cell) 
1 %HPV  
DNA 
(7000copy/cell)
Number 
counted 2.67 5.84 11.9 34.6 141 446 
Standard 
Deviation 1.75 2.49 3.44 5.35 27.5 40.1 
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Figure 9.  Standard curve of the quantification of HPV-16 DNA with dual probe surface 
hybridization method. Both axes are shown in logarithmic scales.  
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CHAPTER 4. GENERAL CONCLUSIONS 
 
The potential of single molecule detection as an analysis tool in biological and medical fields 
is well recognized today. This fast evolving technique will provide fundamental sensitivity to 
pick up individual pathogen molecules, and therefore contribute to a more accurate diagnosis 
and a better chance for a complete cure. Many studies are being carried out to successfully 
apply this technique in real screening fields. 
In this dissertation, several attempts are shown that have been made to test and refine the 
application of the single molecule technique as a clinical screening method. A basic 
applicability was tested with a 100% target content sample, using electrophoretic mobility 
and multiple colors as identification tools. Both electrophorestic and spectral information of 
individual molecule were collected within a second, while the molecule travels along the 
flow in a capillary. Insertion of a transmission grating made the recording of the whole 
spectrum of a dye-stained molecule possible without adding complicated instrumental 
components. Collecting two kinds of information simultaneously and combining them 
allowed more thorough identification, up to 98.8% accuracy.  
Probing mRNA molecules with fluorescently labeled cDNA via hybridization was also 
carried out. The spectral differences among target, probe, and hybrid were interpreted in 
terms of dispersion distances after transmission grating, and used for the identification of 
each molecule. The probes were designed to have the least background when they are free, 
but have strong fluorescence after hybridization via fluorescence resonance energy transfer. 
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The mRNA-cDNA hybrids were further imaged in whole blood, plasma, and saliva, to test 
how far a crude preparation can be tolerated. Imaging was possible with up to 50% of clear 
bio-matrix contents, suggesting a simple lysis and dilution would be sufficient for imaging 
for some cells.  
Real pathogen DNA of human papillomavirus (HPV) type-16 in human genomic DNA was 
probed with fluorescently-labeled probe molecules and imaged. When only the probes were 
stained and hybridized in a vial, it had 6 orders of magnitude dynamic range with a detection 
limit of ~0.7 copy/cell. A second dye was added to lower the false positive levels. Although 
there was a sacrifice of two orders of magnitude in detection limit, the number of false 
positives was reduced to zero.  
HPV-16 DNA was also hybridized and detected on surface-tethered probes. When the entire 
human genomic DNA and HPV was labeled and hybridized, the detection limit was similar 
to that of one-color assay detected in capillary. However, non-specific adsorption was high, 
and the dynamic range was narrow because of saturation of the surface and electrostatic 
repulsion between hybridized targets on the surface. The second probe was introduced to 
lower non-specific adsorption, and the strategy succeeded in 4 orders of magnitude linear 
dynamic range in a log-log plot, along with 2.4 copies/cell detection limit.  
DNA extracts of cell lines that contained a known copy number of HPV-16 DNA were tested 
with the four strategies described above. The calculated numbers from observed molecule 
counts matched the known values. Results from the Pap test sample with added HPV DNA 
were similar to those of purified DNA, suggesting our method is compatible with the 
conventional Pap test sample collection method. 
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Further optimization will be needed before this single molecule level detection and 
identification can actually be used in a real clinical lab, but it has good potential and 
applicability. Improvement such as automated imaging and scanning, more accurate data 
processing software as well as sensitive camera, should help increase the efficiency and 
throughput.  
 
 
 
